Jones Trading Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $135

Jones Trading analyst Catherine Novack initiates coverage on Spruce Biosciences (NASDAQ:SPRB) with a Buy rating and announces Price Target of $135.